- Home
- EVGN vs EVAX Comparison
EVGN vs EVAX Comparison
Compare EVGN & EVAX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EVGN
- EVAX
- Stock Information
- Founded
- EVGN 1999
- EVAX 2008
- Country
- EVGN Israel
- EVAX Denmark
- Employees
- EVGN N/A
- EVAX N/A
- Industry
- EVGN Agricultural Chemicals
- EVAX Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- EVGN Industrials
- EVAX Health Care
- Exchange
- EVGN Nasdaq
- EVAX Nasdaq
- Market Cap
- EVGN 9.7M
- EVAX 8.7M
- IPO Year
- EVGN N/A
- EVAX 2021
- Fundamental
- Price
- EVGN $1.80
- EVAX $2.38
- Analyst Decision
- EVGN Strong Buy
- EVAX Strong Buy
- Analyst Count
- EVGN 1
- EVAX 2
- Target Price
- EVGN $12.00
- EVAX $11.00
- AVG Volume (30 Days)
- EVGN 65.9K
- EVAX 250.1K
- Earning Date
- EVGN 03-06-2025
- EVAX 10-31-2024
- Dividend Yield
- EVGN N/A
- EVAX N/A
- EPS Growth
- EVGN N/A
- EVAX N/A
- EPS
- EVGN N/A
- EVAX N/A
- Revenue
- EVGN $7,478,000.00
- EVAX $3,295,000.00
- Revenue This Year
- EVGN $90.35
- EVAX $4,845.21
- Revenue Next Year
- EVGN $38.71
- EVAX $30.30
- P/E Ratio
- EVGN N/A
- EVAX N/A
- Revenue Growth
- EVGN 30.69
- EVAX N/A
- 52 Week Low
- EVGN $1.20
- EVAX $2.38
- 52 Week High
- EVGN $10.40
- EVAX $68.05
- Technical
- Relative Strength Index (RSI)
- EVGN 57.46
- EVAX 22.18
- Support Level
- EVGN $1.45
- EVAX $3.17
- Resistance Level
- EVGN $1.84
- EVAX $3.90
- Average True Range (ATR)
- EVGN 0.12
- EVAX 0.55
- MACD
- EVGN 0.02
- EVAX -0.04
- Stochastic Oscillator
- EVGN 62.50
- EVAX 0.00
About EVGN Evogene Ltd
Evogene Ltd is a computational biology company targeting to revolutionize product development for life-science based industries, including human health, agriculture, and industrial applications. The company established its technology, the Computational Predictive Biology (CPB) platform. The CPB platform is designed to computationally discover and develop life-science products based on microbes, small molecules and genetic elements as the core components for such products. It holds a number of subsidiaries utilizing the CPB platform, for the development of human microbiome-based therapeutics, medical cannabis, ag-biologicals, ag-chemicals, seed traits and ag-solutions for castor oil production. It generates maximum revenue from the Agriculture segment followed by Industry.
About EVAX Evaxion Biotech A/S
Evaxion Biotech AS is a clinical-stage biotech company that aspires to the exploration of artificial intelligence, or AI, to develop immunotherapies with improved efficacy when compared to currently marketed products for patients with unmet medical needs. Its pipeline programs are derived from its proprietary AI platforms, PIONEER, EDEN, RAVEN, and ObsERV. The company is utilizing these AI platforms to build a drug development pipeline. Its product candidates are; EVX-01 and EVX-02, for the treatment of various cancers, and the third candidate is cancer immunotherapy, EVX-03, for the treatment of various cancers including non-small-cell-lung-cancer, or NSCLC, is in pre-clinical development.